These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37596597)

  • 21. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia.
    Zhang T; Liao D; Hu Y
    Transl Cancer Res; 2023 May; 12(5):1175-1195. PubMed ID: 37304546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
    Shi H; Gao L; Zhang W; Jiang M
    BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia.
    Wu F; Xu G; Li G; Yin Z; Shen H; Ye K; Zhu Y; Zhang Q; Ou R; Liu S
    Front Mol Biosci; 2023; 10():1281141. PubMed ID: 38161382
    [No Abstract]   [Full Text] [Related]  

  • 25. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
    Hua J; Ding T; Shao Y
    Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
    Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
    EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients.
    Nie L; Zhang Y; You Y; Lin C; Li Q; Deng W; Ma J; Luo W; He H
    Hematology; 2022 Dec; 27(1):840-848. PubMed ID: 35924822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia.
    Zhong F; Yao F; Cheng Y; Liu J; Zhang N; Li S; Li M; Huang B; Wang X
    Sci Rep; 2022 Feb; 12(1):1759. PubMed ID: 35110624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
    Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
    Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L
    Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
    Zheng J; Guo J; Cao B; Zhou Y; Tong J
    Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients.
    Huang X; Wang HF; Huang S
    Front Genet; 2022; 13():906880. PubMed ID: 36061188
    [No Abstract]   [Full Text] [Related]  

  • 37. Establishment and validation of a prognostic immune-related lncRNA risk model for acute myeloid leukemia.
    Xie KY; Chen SZ; Wang Y; Zeng ML; Liu XY; Liang Y; Wei J
    Transl Cancer Res; 2023 Dec; 12(12):3693-3702. PubMed ID: 38192996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine metabolism-related genes predict the prognostic risk of acute myeloid leukemia and stratify patients by subtype analysis.
    Zhou J; Zhang N; Zuo Y; Xu F; Cheng L; Fu Y; Yang F; Shu M; Zhou M; Zou W; Zhang S
    Hereditas; 2024 Sep; 161(1):35. PubMed ID: 39300580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer.
    Sheng G; Wang T; Gao Y; Wu H; Wu J
    Sci Rep; 2023 Nov; 13(1):19670. PubMed ID: 37952076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.